Complete Report is available at http://www.sandlerresearch.org/global-non-hodgkin-lymphoma-therapeutics-market-2014-2018.html Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions

1. Global Non-Hodgkin Lymphoma
Therapeutics Market 2014-2018
Order this report by calling
+1 888 391 5441 or Send an email
to sales@sandlerresearch.org
with your contact details and
questions if any.
1© SandlerResearch.org/ Contact sales@sandlerresearch.org
Published: June 2014
Single User PDF: US$ 2500
Corporate User PDF: US$ 3500
No. of Pages: 91

2. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
According to the ”Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018”
report Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to
the production of abnormal lymphocytes.
In normal circumstances, the lymphocytes grow and die. However, in NHL they do
not die; instead they grow and further divide. NHL can begin either in the T-cells or
B-cells, though mostly it begins in the B-cells.
The location of NHL is generally in the lymph nodes, but it can also spread to the
body’s lymphatic system. It has many symptoms, of which swelling in the lymph
nodes, abdominal pain, chest pain, cough, fever, fatigue, and night sweats are the
most prominent.
2© SandlerResearch.org/ Contact sales@sandlerresearch.org
Reach us at
+ 1 888 391 5441 | sales@sandlerresearch.org

3. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
The causes of this disease are still unknown to scientists. NHL is linked with risk
factors such as the overuse of immunosuppressant drugs, viruses such as HIV or
Epstein-Barr, and bacteria such as Helicobacter pylori.
NHL can be diagnosed by urine tests, physical examination for the enlargement of
the lymph nodes, imaging tests (scans) such as magnetic resonance imaging (MRI) or
computerized tomography (CT), and biopsy tests.
Analysts forecast the Global Non-Hodgkin Lymphoma Therapeutics market will grow
at a CAGR of 7.03 percent over the period 2014-2018.
3© SandlerResearch.org/ Contact sales@sandlerresearch.org
Complete Report is available at http://www.sandlerresearch.org/global-non-hodgkin-
lymphoma-therapeutics-market-2014-2018.html .

4. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Non-
Hodgkin Lymphoma Therapeutics market for the period 2014-2018. The Global Non-
Hodgkin Lymphoma Therapeutics market will observe a high growth in the forecast
period. It is due to the availability of the biosimilars at a reduced price across the
NHL market.
This will be mainly due to the growth of the drug Rituxan in the global market. Apart
from that, the market will also grow as a result of the improved diagnostic
techniques to detect NHL. Besides, the increase in public awareness about NHL and
robust drug pipeline for the treatment of NHL are the major influencers in the
growth of the Global Non-Hodgkin Lymphoma Therapeutics market.
4© SandlerResearch.org/ Contact sales@sandlerresearch.org
Inquire Before Buying the Report @ http://www.sandlerresearch.org/inquire-before-
buying?rname=19193 .

5. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
Covered in this Report
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018, has been prepared
based on an in-depth market analysis with inputs from industry experts. The report
covers the Americas, and the EMEA and APAC regions; it also covers the Global Non-
Hodgkin Lymphoma Therapeutics market landscape and its growth prospects in the
coming years. The report also includes a discussion of the key vendors operating in
this market.
5© SandlerResearch.org/ Contact sales@sandlerresearch.org
Complete Report is available at http://www.sandlerresearch.org/global-non-hodgkin-
lymphoma-therapeutics-market-2014-2018.html .

6. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
Key Regions
Americas
EMEA
APAC
Key Vendors
Bristol Myers Squibb Co.
Celgene Corp.
Eli Lilly and Co.
F. Hoffman La-Roche Ltd.
GlaxoSmithKline plc
6© SandlerResearch.org/ Contact sales@sandlerresearch.org
Inquire Before Buying the Report @ http://www.sandlerresearch.org/inquire-before-
buying?rname=19193 .

7. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
Other Prominent Vendors
Accredo Health Group Inc.
Baxter International Inc.
Bayer AG
Cephalon Inc.
Eisai Pharmaceuticals Inc.
Genelabs Technologies Inc.
Hospira Inc.
Johnson & Johnson
Merck & Co. Inc.
Millenium Pharmaceuticals Inc.
Pacira Pharmaceuticals Inc.
Pfizer Inc.
Sanofi SA
Teva Pharmaceuticals Inc.
7© SandlerResearch.org/ Contact sales@sandlerresearch.org
Get Discount on the Report @ http://www.sandlerresearch.org/discount?rname=19193 .

8. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
Key Market Driver
Availability of Biosimilars at a Reduced Price.
Key Market Challenge
High Cost of NHL Drugs.
Key Market Trend
Dominance of NHL Market by Biologics.
8© SandlerResearch.org/ Contact sales@sandlerresearch.org
Browse more Report on Pharmaceutical Market

9. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
9© SandlerResearch.org/ Contact sales@sandlerresearch.org
Get Discount on the Report @ http://www.sandlerresearch.org/discount?rname=19193 .

10. 10© SandlerResearch.org/ Contact sales@sandlerresearch.org
Reach us at
+ 1 888 391 5441 | sales@sandlerresearch.org
Find Us.